000830254 001__ 830254
000830254 005__ 20210129230447.0
000830254 0247_ $$2doi$$a10.1016/j.jmb.2017.03.015
000830254 0247_ $$2WOS$$aWOS:000400720100006
000830254 0247_ $$2altmetric$$aaltmetric:19219212
000830254 0247_ $$2pmid$$apmid:28315663
000830254 037__ $$aFZJ-2017-03827
000830254 082__ $$a570
000830254 1001_ $$0P:(DE-HGF)0$$aVasudevan, Ananda Ayyappan Jaguva$$b0
000830254 245__ $$aEnhancing the Catalytic Deamination Activity of APOBEC3C Is Insufficient to Inhibit Vif-Deficient HIV-1
000830254 260__ $$aAmsterdam [u.a.]$$bElsevier$$c2017
000830254 3367_ $$2DRIVER$$aarticle
000830254 3367_ $$2DataCite$$aOutput Types/Journal article
000830254 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1496057614_26299
000830254 3367_ $$2BibTeX$$aARTICLE
000830254 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000830254 3367_ $$00$$2EndNote$$aJournal Article
000830254 520__ $$aThe retroviral restriction factors of the APOBEC3 (A3) cytidine deaminase family catalyze the deamination of cytidines in single-stranded viral DNA. APOBEC3C (A3C) is a strong antiviral factor against viral infectivity factor (vif)-deficient simian immunodeficiency virus Δvif, which is, however, a weak inhibitor against human immunodeficiency virus (HIV)-1 for reasons unknown. The precise link between the antiretroviral effect of A3C and its catalytic activity is incompletely understood. Here, we show that the S61P mutation in human A3C (A3C.S61P) boosted hypermutation in the viral genomes of simian immunodeficiency virus Δvif and murine leukemia virus but not in human immunodeficiency virus HIV-1Δvif. The enhanced antiviral activity of A3C.S61P correlated with enhanced in vitro cytidine deamination. Furthermore, the S61P mutation did not change the substrate specificity of A3C, ribonucleoprotein complex formation, self-association, Zinc coordination, or viral incorporation features. We propose that local structural changes induced by the serine-to-proline substitution are responsible for the gain of catalytic activity of A3C.S61P. Our results are a first step toward an understanding of A3C's DNA binding capacity, deamination-dependent editing, and antiviral functions at the molecular level. We conclude that the enhanced enzymatic activity of A3C is insufficient to restrict HIV-1, indicating an unknown escape mechanism of HIV-1.
000830254 536__ $$0G:(DE-HGF)POF3-553$$a553 - Physical Basis of Diseases (POF3-553)$$cPOF3-553$$fPOF III$$x0
000830254 7001_ $$0P:(DE-HGF)0$$aHofmann, Henning$$b1
000830254 7001_ $$0P:(DE-Juel1)132029$$aWillbold, Dieter$$b2$$ufzj
000830254 7001_ $$0P:(DE-HGF)0$$aHäussinger, Dieter$$b3
000830254 7001_ $$0P:(DE-Juel1)132009$$aKönig, Bernd$$b4$$ufzj
000830254 7001_ $$0P:(DE-HGF)0$$aMünk, Carsten$$b5$$eCorresponding author
000830254 773__ $$0PERI:(DE-600)1355192-9$$a10.1016/j.jmb.2017.03.015$$n8$$p1171–1191$$tJournal of molecular biology$$v429$$x0022-2836$$y2017
000830254 8564_ $$uhttps://juser.fz-juelich.de/record/830254/files/Enhancing%20the%20Catalytic%20Deamination%20Activity%20of%20APOBEC3C%20Is%20Insufficient%20to%20Inhibit%20Vif-Deficient%20HIV-1..pdf$$yRestricted
000830254 8564_ $$uhttps://juser.fz-juelich.de/record/830254/files/Enhancing%20the%20Catalytic%20Deamination%20Activity%20of%20APOBEC3C%20Is%20Insufficient%20to%20Inhibit%20Vif-Deficient%20HIV-1..gif?subformat=icon$$xicon$$yRestricted
000830254 8564_ $$uhttps://juser.fz-juelich.de/record/830254/files/Enhancing%20the%20Catalytic%20Deamination%20Activity%20of%20APOBEC3C%20Is%20Insufficient%20to%20Inhibit%20Vif-Deficient%20HIV-1..jpg?subformat=icon-1440$$xicon-1440$$yRestricted
000830254 8564_ $$uhttps://juser.fz-juelich.de/record/830254/files/Enhancing%20the%20Catalytic%20Deamination%20Activity%20of%20APOBEC3C%20Is%20Insufficient%20to%20Inhibit%20Vif-Deficient%20HIV-1..jpg?subformat=icon-180$$xicon-180$$yRestricted
000830254 8564_ $$uhttps://juser.fz-juelich.de/record/830254/files/Enhancing%20the%20Catalytic%20Deamination%20Activity%20of%20APOBEC3C%20Is%20Insufficient%20to%20Inhibit%20Vif-Deficient%20HIV-1..jpg?subformat=icon-640$$xicon-640$$yRestricted
000830254 8564_ $$uhttps://juser.fz-juelich.de/record/830254/files/Enhancing%20the%20Catalytic%20Deamination%20Activity%20of%20APOBEC3C%20Is%20Insufficient%20to%20Inhibit%20Vif-Deficient%20HIV-1..pdf?subformat=pdfa$$xpdfa$$yRestricted
000830254 909CO $$ooai:juser.fz-juelich.de:830254$$pVDB
000830254 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000830254 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000830254 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000830254 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ MOL BIOL : 2015
000830254 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000830254 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000830254 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000830254 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000830254 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000830254 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000830254 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000830254 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000830254 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000830254 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000830254 9141_ $$y2017
000830254 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$aExternal Institute$$b0$$kExtern
000830254 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)132029$$aForschungszentrum Jülich$$b2$$kFZJ
000830254 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)132009$$aForschungszentrum Jülich$$b4$$kFZJ
000830254 9131_ $$0G:(DE-HGF)POF3-553$$1G:(DE-HGF)POF3-550$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lBioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences$$vPhysical Basis of Diseases$$x0
000830254 920__ $$lyes
000830254 9201_ $$0I:(DE-Juel1)ICS-6-20110106$$kICS-6$$lStrukturbiochemie$$x0
000830254 980__ $$ajournal
000830254 980__ $$aVDB
000830254 980__ $$aI:(DE-Juel1)ICS-6-20110106
000830254 980__ $$aUNRESTRICTED
000830254 981__ $$aI:(DE-Juel1)IBI-7-20200312